International Conferences
Over the course of the project, various members of the InPharma network – PIs and ESRs alike – have visited and contributed to a number of international conferences.
2024
- 22-23.10.2024, AAPS 2024 PharmSci 360, Salt Lake City, UT
Shirin Dietrich (ESR9), In vitro evaluation of apparent drug concentrations in the contents of upper gastrointestinal lumen during the post-disintegration period in the fed state: Design and preliminary performance assessment of BioGITfed - 07.10.24-08.10.2024, OSP community conference, Basel, Switzerland
Paul Vrenken (ESR10), oral presentation: Extending the OSP oral absorption toolbox: An end-to-end Physiology-Based Biopharmaceutics Modeling (PBBM) approach - 14.07.2024 – 17.07.2024, GPEN meeting, Copenhagen, Denmark
Shaida Panbachi (ESR5), podium talk and poster presentation: Abiraterone acetate fixed-dosed combinations with ibuprofen-based therapeutic eutectic (and deep eutectic) solvents (podium presentation) - 25.06.2024-28.06.2024, 32nd Population Approach Group Europe (PAGE) meeting, Odense, Denmark
Paul Vrenken (ESR10), poster presentation: Development of a novel open-source Physiology-Based Biopharmaceutics Modelling (PBBM) framework using the Open System Pharmacology suite - 23.05.2024-25.05.2024, EUFEPS Annual Meeting 2024, Debrecen, Hungary
Nicolas Pätzmann (ESR3), poster presentation: The role of drug melting point depression in co-milling: A case study with the high-Tg glass former Apremilast - 14.05.2024, European Drug Absorption Network Meeting 2024, Leuven, Belgium
Justus Lange (ESR2), oral presentation: Exploring the impact of Solupuls® clouding behaviour in FASSIF-V1
Shirin Dietrich (ESR9), oral presentation: Processes limiting oral drug absorption when amorphous solid dispersions are administered after a high-calorie, high-fat meal: Sporanox® pellets - 12.04.2024, NordicPOP exchange meeting, Tromsoe, Norway
Florentin Lukas Holzem (ESR11), oral presentation: Microdialyis as a biopharmaceutical tool to distinguish molecularly and colloid-associated drug in a time-resolved manner
Matteo Guidetti (ESR1), oral presentation: Pharmaceutical co-crystals: an attractive option for overcoming drug limitations
Felix Paulus (ESR13), oral presentation: Impact of digestion on drug absorption from supersaturated lipid-based formulations - 18.03.2024-21.03.2024, 14th PBP World Meeting, Vienna, Austria
Matteo Guidetti (ESR1), poster presentation: High-throughput approach to accelerate the co-crystal screening of the calcium-channel blocker cilnidipine.
Nicolas Pätzmann (ESR3), poster presentation: Influence of co-milling conditions on drugs of different glass forming ability classes
Lotte Ejskjær (ESR4), poster presentation: Computational predictions of biorelevant solubility ratio upon dispersion and digestion of lipid-based formulations
Shaida Panbachi (ESR5), poster presentation: Hydrophobic deep eutectic solvents (HDES) as a novel oil phase in a lipid-based formulation of venetoclax
Egis Zeneli (ESR6), poster presentation: Broad high throughput physiological screening for mechanistic understanding of media-related effects on drug solubility
Florentin Lukas Holzem (ESR11), poster presentation: Using molecularly dissolved drug concentrations in PBBMs improves the oral absorption prediction from supersaturating formulations
Malte Bøgh Senniksen (ESR12), poster presentation: Implementation of a high throughput ASD screening workflow in the refined developability classification system (rDCS)
2023
- 22.10.2023-25.10.2023, AAPS 2023 PharmSci 360, Orlando, United States of America
Nicolas Pätzmann (ESR3), poster presentation: Computational prediction of initial dissolution gains after application of Co-milling
Shirin Dietrich (ESR9), poster presentation: Itraconazole concentrations in the colloidal aqueous phase of contents of upper small intestine after the standard meal and their relevance to itraconazole plasma levels
Kristian Beran (ESR7), poster presentation: A case study on the applicability of the refined Developability Classification System to identify compounds suitable for biowaivers: Voriconazole
Shirin Dietrich (ESR9), poster presentation: Understanding the drug gastrointestinal transfer process of disintegrated dose units after the standard high-calory high-fat meal
Justus Lange (ESR2), Malte Bøgh Senniksen (ESR12), poster presentation: Influence of drug load and surfactant concentration on the release performance of ternary amorphous solid dispersions
Laurin Zöller (ESR8), poster presentation: Comparison of drug dissolution, supersaturation and precipitation kinetics in the USP 2 and μDISS Profiler™ apparatus
Paul Vrenken (ESR10), poster presentation: Development of a novel, semi-mechanistic in vitro dissolution model to inform Physiology-Based Biopharmaceutics modeling frameworks
Laurin Zöller (ESR8), poster presentation: New insights into non-classical crystallization of pharmaceutical solids: Chemically-specific coherent Raman imaging of liquid-liquid phase separation. - 17.10.2023-20.10.2023, Janssen Global Fellowship Science Symposium, Beerse, Belgium
Lotte Ejskjær (ESR4), poster presentation: Computational prediction of biorelevant drug solubility in solubilizing excipients - 10.09.2023-12.09.2023, 12th Crystal Form convention, Bologna, Italy
Matteo Guidetti (ESR1), oral presentation: Exploring the Cocrystal Landscape of Posaconazole by Combining High-Throughput Screening Experimentation with Computational Chemistry - 04.09.2023-06.09.2023, IAPC-10 Meeting, Belgrade, Serbia
Matteo Guidetti (ESR1), poster presentation: Polymorphic conversion of a hydrophobic drug in water: Posaconazole suspensions - 31.05.2023-02.06.2023, EUFEPS Annual Meeting 2023, Lisbon, Portugal
Lotte Ejskjær (ESR4), poster presentation: In-line real-time assessment of the solubility change of lipid-based formulation upon dispersion and digestion
Shirin Dietrich (ESR9), poster presentation: Proposing in vitro testing conditions for the evaluation of intragastric disintegration of solid dose units in the fed state
Kristian Beran (ESR7), poster presentation: Target particle size estimations for oral drug formulations using the refined Developability Classification System (rDCS) - 20.03.2023 – 21.03.2023, 4th European Conference on Pharmaceutics, Marseille, France
Justus Lange (ESR2), poster presentation: Synergistic solubilization effects facilitated by the combination of Soluplus® with sodium oleate
Shaida Panbachi (ESR5), poster presentation: Polymer-embedded Deep Eutectic Solvents (PEDES) as innovative drug-supersaturating delivery system
Egis Zeneli (ESR6), Justus Lange (ESR2) co-author, poster presentation: A study of hydrophobic molecular drug interactions with polymer in solution phase
Kristian Beran (ESR7), poster presentation: Application of the refined Developability Classification System (rDCS): Approaches to assess dissolution rate limitations of voriconazole and lemborexant
2022
- 24.11.2022, DDPS science summit
Malte Bøgh Senniksen (ESR12), Networking and introduction presentation: Application of an end–to-end, animal-free modelling approach to the development of enabling drug products: focus on amorphous solid dispersions (ASD) - 16.10.2022 – 19.10.2022, 2022 AAPS PharmSci 360, Boston, USA
Lotte Ejskjær (ESR4), poster presentation: Developing an in vitro lipolysis model for real-time analysis of drug concentrations during digestion of lipid-based formulations - 22.09.2022, College of Medicine and Health “from Molecules to People”, University College Cork, Cork, Ireland
Lotte Ejskjær (ESR4), poster presentation: Developing an in vitro lipolysis model for real-time analysis of drug concentrations during digestion of lipid-based formulations - 29.08.2022 – 31.08.2022, SweDeliver 2022, Uppsala, Sweden
Laurin Zöller (ESR8), poster presentation: Effect of counterions on the solubility and dissolution of sodium ibuprofen - 26.08.2022 – 28.08.2022, Janssen CPDS Science Day 2022, Beerse, Belgium
Kristian Beran (ESR7), poster presentation: Application of the refined Developability Classification System (rDCS) to voriconazole: A comparison to in vivo formulation selection strategies
Felix Paulus (ESR13), poster presentation: Impact of digestion on the absorption of Cinnarizine from supersaturated lipid solutions - 10.08.2022 – 12.08.2022, NordicPOP annual meeting 2022, Helsinki, Finland/Stockholm/Sweden
Florentin Lukas Holzem (ESR11), poster presentation: Microdialysis and nanofiltration allow to distinguish molecularly dissolved from colloid-associated drug concentrations during biomimetic dissolution testing of supersaturating formulations - 16.06.2022, PARC Symposium, Prague, Czech Republic
Nicolas Pätzmann (ESR3), poster presentation: Computational tools to predict dissolution rate enhancement by Co-Grinding - 10.05.2022 – 12.05.2022, 2022 JRD Global Postdoc & PhD Fellowship Symposium, Spring House, USA
Kristian Beran (ESR7), poster presentation: Application of the refined developability classification system to antifungals: voriconazole and itraconazole - 28.03.2022 – 31.03.2022, PBP World Meeting 2022, Rotterdam, Netherlands
Kristian Beran (ESR7), Malte Bøgh Senniksen (ESR12), poster presentation: Application of the refined developability classification system to antifungals: voriconazole and itraconazole - 21.03.2022 – 22.03.2022, UNGAP group meeting, Lisbon, Portugal
Florentin Lukas Holzem (ESR11), poster presentation: Microdialysis and nanofiltration allow to distinguish molecularly dissolved from colloid-associated drug concentrations during biomimetic dissolution testing of supersaturating formulations
Questions about our dissemination activities and results? Contact us:
Prof. Brendan Griffin, University College Cork
InPharma Coordinator
[email protected]
Follow us:
Go to section